Overview

CGB-400 for the Reduction of Facial Redness

Status:
Completed
Trial end date:
2019-04-18
Target enrollment:
Participant gender:
Summary
Open-label multicenter study using CGB-400 Gel (cosmetic) to reduce facial redness
Phase:
Phase 1
Details
Lead Sponsor:
CAGE Bio Inc.
Collaborator:
ethica Clinical Research Inc.